A dose-controlled system for air-liquid interface cell exposure and application to zinc oxide nanoparticles
暂无分享,去创建一个
Barbara Rothen-Rutishauser | Holger Schulz | Otmar Schmid | Christina Brandenberger | H. Schulz | B. Lentner | E. Karg | O. Schmid | B. Rothen‐Rutishauser | G. Ferron | C. Brandenberger | Erwin Karg | A. Lenz | Bernd Lentner | George A Ferron | Anke Gabriele Lenz | Vlad Dittrich | V. Dittrich
[1] J. Gordon,et al. The oscillation frequency of a quartz resonator in contact with liquid , 1985 .
[2] W G Kreyling,et al. Dose-controlled exposure of A549 epithelial cells at the air-liquid interface to airborne ultrafine carbonaceous particles. , 2006, Chemosphere.
[3] X. Margot,et al. Computational study on the deposition of ultrafine particles from Diesel exhaust aerosol , 2006 .
[4] S. Sanjar,et al. Treating systemic diseases via the lung. , 2001, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[5] M. Kondo,et al. AIR EXPOSURE CAUSES OXIDATIVE STRESS IN CULTURED BOVINE TRACHEAL EPITHELIAL CELLS AND PRODUCES A CHANGE IN CELLULAR GLUTATHIONE SYSTEMS , 2003, Experimental lung research.
[7] J. Knebel,et al. In vitro exposure of isolated cells to native gaseous compounds--development and validation of an optimized system for human lung cells. , 2001, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[8] Robert N Grass,et al. Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. , 2005, Environmental science & technology.
[9] C. Ehrhardt,et al. Large Porous Particle Impingement on Lung Epithelial Cell Monolayers—Toward Improved Particle Characterization in the Lung , 2003, Pharmaceutical Research.
[10] Susanne Krauss-Etschmann,et al. Health effects of ambient particulate matter--biological mechanisms and inflammatory responses to in vitro and in vivo particle exposures. , 2008, Inhalation toxicology.
[11] R. Peters,et al. From fluorescence nanoscopy to nanoscopic medicine. , 2008, Nanomedicine.
[12] H. Krug,et al. In Vitro Testing of Inhalable Fly Ash at the Air Liquid Interface , 2008 .
[13] Jan W. Knebel,et al. DEVELOPMENT AND VALIDATION OF A SEMIAUTOMATIC SYSTEM FOR GENERATION AND DEPOSITION OF SPRAYS ON ISOLATED CELLS OF THE RESPIRATORY TRACT , 2001 .
[14] Peter Gehr,et al. Particle-Lung Interactions , 2000 .
[15] I. Jaspers,et al. Ultrafine carbon particles induce interleukin-8 gene transcription and p38 MAPK activation in normal human bronchial epithelial cells. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[16] Joel G Pounds,et al. Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.
[17] Vicki Stone,et al. Efficacy of Simple Short-Term in Vitro Assays for Predicting the Potential of Metal Oxide Nanoparticles to Cause Pulmonary Inflammation , 2008, Environmental health perspectives.
[18] D. Geller,et al. New aerosol delivery devices for cystic fibrosis. , 2009, Respiratory care.
[19] B. Rothen‐Rutishauser,et al. An optimized in vitro model of the respiratory tract wall to study particle cell interactions. , 2006, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[20] U. Mohr,et al. CULTEX--an alternative technique for cultivation and exposure of cells of the respiratory tract to airborne pollutants at the air/liquid interface. , 2000, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[21] Gerhard Scheuch,et al. Clearance of Particles Deposited in the Lungs , 2000 .
[22] J. Patton,et al. (D) Routes of delivery: Case studies , 1992 .
[23] Malgorzata Smola,et al. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases , 2008, International journal of nanomedicine.
[24] J. Pounds,et al. Macrophage responses to silica nanoparticles are highly conserved across particle sizes. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.
[25] George G. Guilbault,et al. Commercial quartz crystal microbalances-Theory and applications , 1999 .
[26] B. Rothen‐Rutishauser,et al. A novel cell compatible impingement system to study in vitro drug absorption from dry powder aerosol formulations. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[27] Benjamin Gilbert,et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. , 2008, ACS nano.
[28] H. Katinger,et al. Nebulization of Liposomal rh-Cu/Zn–SOD with a Novel Vibrating Membrane Nebulizer , 2006, Journal of liposome research.
[29] M. Knoch,et al. The customised electronic nebuliser: a new category of liquid aerosol drug delivery systems , 2005, Expert opinion on drug delivery.
[30] H. Schreier,et al. Simulated lung transfection by nebulization of liposome cDNA complexes using a cascade impactor seeded with 2-CFSME0-cells. , 1998, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.
[31] B. Mossman,et al. A new method for quantifiable and controlled dosage of particulate matter for in vitro studies: the electrostatic particulate dosage and exposure system (EPDExS). , 2008, Toxicology in vitro : an international journal published in association with BIBRA.
[32] A. Peters,et al. Respiratory effects are associated with the number of ultrafine particles. , 1997, American journal of respiratory and critical care medicine.
[33] H. Krug,et al. Nanoecotoxicology: nanoparticles at large. , 2008, Nature nanotechnology.
[34] O. Schmid,et al. Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model. , 2010, Toxicology and applied pharmacology.
[35] Barry H. Smith,et al. A continuous tumor‐cell line from a human lung carcinoma with properties of type II alveolar epithelial cells , 1976, International journal of cancer.
[36] W. Kreyling,et al. Health implications of nanoparticles , 2006 .
[37] Sophie Lanone,et al. Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines , 2009, Particle and Fibre Toxicology.
[38] J. Heyder,et al. Deposition of particles in the human respiratory tract in the size range 0.005–15 μm , 1986 .
[39] G. P. Martin,et al. The permeability of large molecular weight solutes following particle delivery to air-interfaced cells that model the respiratory mucosa. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[40] A. Maynard,et al. Airborne Nanostructured Particles and Occupational Health , 2005 .